Sign In
Buy CYTK
$80.01
+0.84 (+1.06%)
At Close: Jun 23, 2026
NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytokinetics, Incorporated ("Cytokinetics" or "the C
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) on behalf of investors
Cytokinetics to Hold Annual Meeting of Stockholders
04:00pm, Wednesday, 07'th May 2025
SOUTH SAN FRANCISCO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 14, 2025
Cytokinetics Q1 Earnings Beat, Aficamten Target Action Date Extended
02:15pm, Wednesday, 07'th May 2025
CYTK reports narrower-than-expected Q1 loss. However, the target action date for aficamten in obstructive HCM has been extended by the FDA to provide time for reviewing a REMS submission made at the a
Cytokinetics: Strong Buy As FDA's 3-Month Delay Doesn't Derail Aficamten's Approval Outlook
11:29am, Wednesday, 07'th May 2025
The FDA extended aficamten's review by three months for REMS safety program finalization, causing Cytokinetics' stock to drop over 11%. The REMS requirement is expected and does not indicate fundament
NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) con
NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytokinetics, Incorporated ("Cytokinetics" or "the C
Cytokinetics, Incorporated (CYTK) Q1 2025 Earnings Call Transcript
01:56am, Wednesday, 07'th May 2025
Cytokinetics, Incorporated (NASDAQ:CYTK ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Diane Weiser - Senior Vice President, Corporate Affairs Robert Blum - President &
Did Cytokinetics, Incorporated Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CYTK
06:45pm, Tuesday, 06'th May 2025
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) con
CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm
06:12pm, Tuesday, 06'th May 2025
LOS ANGELES , May 6, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cytokinetics, Inco
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
06:05pm, Tuesday, 06'th May 2025
Cytokinetics (CYTK) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.41. This compares to loss of $1.33 per share a year ago.
Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
04:00pm, Tuesday, 06'th May 2025
PDUFA Date for Aficamten in Obstructive HCM Extended by FDA to December 26, 2025 Topline Results from MAPLE-HCM Expected in May Enrollment Completed in ACACIA-HCM; Topline Results Expected in 1H 2026
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) con
Bronstein, Gewirtz & Grossman, LLC Encourages Cytokinetics, Incorporated (CYTK) Investors to Inquire about Securities Investigation
10:00am, Tuesday, 06'th May 2025
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytokinetics, Incorporated ("Cytokinetics" or "the Compan
Cytokinetics, Incorporated (CYTK) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
04:00pm, Monday, 05'th May 2025
NEW YORK, NY / ACCESS Newswire / May 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) con
